Atherosclerosis risk factors in young patients formerly treated for idiopathic nephrotic syndrome

Pediatric Nephrology

Volumn 24, Issue 3, 2009, Pages 549-554

  Kniazewska, Maria H ^a   Obuchowicz, Anna K ^a   Wielkoszyński, Tomasz ^a   Zmudzińska Kitczak, Joanna ^a   Urban, Katarzyna ^a   Marek, Marta ^a   Witanowska, Jolanta ^a   Sieroń Stoltny, Karolina ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Atherosclerosis; Body composition; C reactive protein; Homocysteine; Intima media thickness; Plasma lipids; Steroid sensitive idiopathic nephrotic syndrome

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; STEROID; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BODY COMPOSITION; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; HUMAN; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; RECURRENCE RISK; RELAPSE; RISK FACTOR; SCHOOL CHILD; STEROID THERAPY;

ADOLESCENT; ADULT; APOLIPOPROTEINS B; ATHEROSCLEROSIS; CHILD; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; GLUCOCORTICOIDS; HOMOCYSTEINE; HUMANS; MALE; NEPHROTIC SYNDROME; RISK FACTORS; YOUNG ADULT;

EID: 59849101805     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-008-1029-1     Document Type: Article

References (28)

1. Orth SR, Ritz E (1998) The nephrotic syndrome. N Engl J Med 17:1202-1211
2. Thabet MA, Salcedo JR, Chan JC (1993) Hyperlipidemia in childhood nephrotic syndrome. Pediatr Nephrol 7:559-566
3. Radhakrishnan J, Appel AS, Valeri A, Appel GB (1993) The nephrotic syndrome, lipids and risk factors for cardiovascular disease. Am J Kidney Dis 22:135-142
4. Mérouani A, Lévy E, Mongeau JG, Robitaille P, Lambert M, Delvin EE (2003) Hyperlipidemic profiles during remission in childhood idiopathic nephrotic syndrome. Clin Biochem 36:571-574
5. Dogra GK, Herrmann S, Irish AB, Thomas MA, Watts GF (2002) Insulin resistance, dyslipidaemia, inflammation and endothelial function in nephrotic syndrome. Nephrol Dial Transplant 17:2220-2225
6. Kuo K, Still R, Cale S, McDowell I (1997) Standardization (external and internal) of HPLC assay for plasma homocysteine. Clin Chem 43:1653-1655
7. Minniti G, Piana A, Armani U, Cerone R (1998) Determination of plasma and serum homocysteine by high-performance liquid chromatography with fluorescence detection. J Chromatogr A 828:401-405
8. Ruth EM, Kemper MJ, Leumann EP, Laube GF, Neuhaus TJ (2005) Children with steroid-sensitive nephrotic syndrome come of age: Long-term outcome. J Pediatr 147:202-207
9. Lewis MA, Baildom EM, Davis N, Houston IB, Postlethwaite RJ (1989) Nephrotic syndrome: From toddlers to twenties. Lancet 1:255-259
10. Foster BJ, Shults J, Zemel BS, Leonard MB (2004) Interactions between growth and body composition in children treated with high-dose chronic glucocorticoids. Am J Clin Nutr 80:1334-1341
11. Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux MF, Landais P, Lesavre P, Chauveau D, Knebelmann B, Broyer M, Grünfeld JP, Niaudet P (2003) Steroid-sensitive nephrotic syndrome: From childhood to adulthood. Am J Kidney Dis 41:550-557
12. Adhikari M, Manikkam NE, Coovadia HM (1992) Effects of repeated courses of daily steroids and of persistent proteinuria on linear growth in children with nephrotic syndrome. Pediatr Nephrol 6:4-9
13. Hung YT, Yang LY (2006) Follow-up of linear growth of body height in children with nephrotic syndrome. J Microbiol Immunol Infect 39:422-425
14. Matsukura H, Inaba S, Shinozaki K, Yanagihara T, Hara M, Higuchi A, Takada T, Tanizawa T, Miyawaki T (2001) Influence of prolonged corticosteroid therapy on the outcome of steroid-responsive nephrotic syndrome. Am J Nephrol 21:362-367
15. Kitamura M (1992) Growth retardation in children with frequent relapsing nephrotic syndrome on steroid-improvement of height velocity after administration of immunosuppressive agent. Nippon Jinzo Gakkai Shi 34:117-124
16. Jabłońska J (2004) Distant effects of steroid therapy in the nephrotic syndrome of childhood. Ann Acad Med Stetin 50:17-27
17. Drozdz D, Sancewicz-Pach K, Wierzchowska-Słowiaczek E (2000) Value of bioelectrical impedance analysis in the assessment of body water in children with nephrotic syndrome: Initial results. Pol Merkuriusz Lek 8:224-225
18. Ksia̧zek J, Niemirska A, Lipka M, Grenda R (2006) Evaluation of arterial intima-media thickness (IMT) in children with idiopathic nephrotic syndrome - preliminary report. Przegl Lek 63 [Suppl 3]:205-207
19. Falaschi F, Ravelli A, Martignoni A, Migliavacca D, Sartori M, Pistorio A, Perani G, Martini A (2000) Nephrotic-range proteinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum 43:1405-1409
20. Woo KS, Chook P, Yu CW, Sung RYT, Qiao M, Leung SSF, Lam CWK, Metreweli C, Celermajer DS (2004) Effects of diet and exercise on obesity-related vascular dysfunction in children. Circulation 109:1981-1986
21. Rodenburg J, Vissers MN, Wiegman A, van Trotsenburg ASP, van der Graaf A, de Groot E, Wijburg FA, Kastelein JJP, Hutten B (2007) Statin treatment in children with familial hypercholesterolemia: The younger, the better. Circulation 116:664-668
22. Zilleruelo G, Hsia SL, Freundlich M, Gorman HM, Strauss J (1984) Persistence of serum lipid abnormalities in children with idiopathic nephrotic syndrome. J Pediatr 104:61-64
23. Kuúma E, Roszkowska-Blaim M (2006) Lipids abnormalities in children with refractory nephrotic proteinuria. Przegl Lek 63 [Suppl 3]:201-204
24. Pritchard PR (2000) Measurement and clinical significance of lecithin: cholesterol acyltransferase. In: Rifai N, Warnick GR, Dominiczak MH (eds) Handbook of lipoprotein testing, 2nd edn. AACC Press, Washington
25. Wasilewska A, Zoch-Zwierz W, Tobolczyk J, Tenderenda E (2007) High-sensitivity C-reactive protein (hs-CRP) level in children with nephrotic syndrome. Pediatr Nephrol 22:403-408
26. Podda GM, Lussana F, Moroni G, Faioni EM, Lombardi R, Fontana G, Ponticelli C, Maioli C, Cattaneo M (2007) Abnormalities of homocysteine and B vitamins in the nephrotic syndrome. Thromb Res 120:647-652
27. Joven J, Arcelús R, Camps J, Ordóñez-Llanos J, Vilella E, González-Sastre F, Blanco-Vaca F (2000) Determinants of plasma homocyst(e)ine in patients with nephrotic syndrome. J Mol Med 78:147-154
28. Arnadottir M, Hultberg B, Berg AL (2001) Plasma total homocysteine concentration in nephrotic patients with idiopathic membranous nephropathy. Nephrol Dial Transplant 16:45-47